MDACC Study Summary BS01-129 (Archived)

Study Summary
No. BS01-129:.......Cancer Prevention......Alex Prokhorov......Behavioral Science

Study Summary Title



Study Summary Number:	BS01-129

Study Title:	Health Care Team Approach to Smoking Cessation: Enhanced Tobacco Outreach Education Program (eTOEP)

Physician

New Patient Referral



Name:	Alex Prokhorov	Patients Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Dept:	Behavioral Science	Referring MD Call:	800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Phone:	713-792-0919 Contact us about clinical trials

General Information



Disease Group:	Cancer Prevention	Supported By:	N/A

Phase of Study:	N/A	Return Visit:	n/a

Treatment Agents:	None	Home Care:	n/a

Treatment Loc:	Independent Multicenter Arrangements

Estimated Length of Stay in Houston:	n/a


Description/ Intervention:	The goal of this behavioral research study is to decrease cancer risk among community residents through an integrated health care provider approach

Study Objectives / Outcomes

AIM 1:

To develop an accredited continuing education training program for each of the target healthcare provider groups. M. D. Anderson's Tobacco Outreach Education Program (TOEP) for healthcare providers materials and the

RX for change

program for pharmacists will serve as foundations for the new,

enhanced

TOEP (eTOEP). The training will be comprehensive in nature, adhering to the recommendations set forth in the Clinical Practice Guideline for Treating Tobacco Use and Dependence.

¹⁴

Training will be tailored to the practice orientation for each of the healthcare provider groups.

AIM 2:

To implement the training program among approximately 192 providers (96 physicians, 96 pharmacists) in 16 communities from centralized locations within 200 miles of Houston (Houston, Austin, Baytown, and Victoria), and to evaluate physicians' and pharmacists' knowledge, skills and satisfaction with the training. Training will be conducted through live presentation, videotaped presentations, and web-based training.

AIM 3:

To evaluate the impact of the training program in group-randomized trials among healthcare providers and their patients, a 2 x 2 design with an equal number of communities (four) will be represented in each cell, for a total of 16 communities. Four communities will be quad-matched by race/ethnicity and age and will be randomized into the four training conditions: 1) pharmacists and physicians both trained in tobacco cessation, 2) pharmacists trained in tobacco cessation and physicians trained in skin cancer prevention , 3) physicians trained in tobacco cessation and pharmacists trained in skin care prevention, 4) neither pharmacists nor physicians trained in tobacco cessation, but both trained in skin cancer prevention.

AIM 4:

To evaluate the proposed tobacco cessation counseling strategies for their costs and benefits.

Study Status Information



Study Activation / Registration Date:	02/03/2003

IRB Review and Approval Date:	06/20/2001

Study Type:	Therapeutic

Recruitment Status:	Terminated

Projected Accrual:	4128

Enrollment Eligibility

If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:

1) All participants, patients and healthcare providers, will be recruited from 16 target communities located within 200 miles of Houston (Houston, Austin, Baytown, and Victoria) . The size of the target communities ranges from about 32,195 to 2,279,541.

2) Longitudinal Cohort Study. Patient participants who (a) smoke at least 1 cigarette/day; (b) speak and read English or Spanish; (c) have a signed participation agreement form; (d) agree to complete the baseline and follow-up surveys and provide a saliva sample at the end of the study; and (e) are within 18-75 years of age.

3) Cross-Sectional Study. Patient participants for the cross-sectional study must be able to speak either English or Spanish. Both tobacco users and nonusers will be included, because the Clinical Practice Guideline encourages asking about tobacco use, the first of the 5 "A"s of tobacco cessation counseling.

4) Healthcare Providers. All physicians and pharmacists from the 16 communities will be eligible for the TEAM training, but healthcare "clusters" will be used for evaluation of outcomes. Family practice clinics and pharmacists will participate in the cohort and cross-sectional portions of the study, while OBGYNs and pediatricians will be included only in the cross-sectional portion.

Exclusion Criteria:

1) Non-English, or non-Spanish speaking individuals

2) Subjects younger than 18 are not eligible.

Links

Registration Number: Not Applicable Clinical Trial